Refex Life Sciences Private Limited

Refex Life Sciences Private Limited - chemicals and materials in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U33112TN2021PTC141761 Incorporated 03 March 2021 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company chemicals and materials
Revenue · FY 2025
₹4.86 Cr
▲ 146% YoY
Net loss · FY 2025
₹8.14 Cr
Net margin -167.3%
EBITDA · FY 2025
-₹4.95 Cr
EBITDA margin -101.7%
Authorised capital
₹500 Cr
Registered with MCA
Paid-up capital
₹162.13 Cr
Issued & subscribed
Open charges
₹460 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings

About Refex Life Sciences Private Limited

Data last updated:

Refex Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Sherisha Technologies Private Limited. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 03 March 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33112TN2021PTC141761. Its GSTIN is 33AAUCA8721D1ZN (Tamil Nadu).

The company has an authorised share capital of ₹500 Cr and a paid-up capital of ₹162.13 Cr. It is led by directors Dinesh Kumar Agarwal and Anil Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, a growth of 146% compared to the previous year. For the same year it recorded a net loss of ₹8.14 Cr (net margin -167.3%) and EBITDA of -₹4.95 Cr (EBITDA margin -101.7%). Revenue has grown at a compounded annual rate (CAGR) of 559% over three years.

As per MCA filings, the company has open charges of ₹460 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website refex.co.in.

Company details

CIN U33112TN2021PTC141761
Registration Number 141761
Incorporation Date 03 March 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Parent Company Sherisha Technologies Private Limited
Compliance Status Active Compliant

Contact details

Refex Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is refex.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Second Floor Refex Towers Sterling Road Signal, 313 Valluvar Kottam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Refex Life Sciences Private Limited, buy the company report.

Comprehensive company report
Refex Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Refex Life Sciences Private Limited

FY 2025 filings available

Refex Life Sciences Private Limited reported revenue of ₹4.86 Cr (up 146% YoY) for FY 2025.

Revenue · FY 2025
₹4.86 Cr ▲ 146%
Net loss · FY 2025
₹8.14 Cr margin -167.3%
EBITDA · FY 2025
-₹4.95 Cr margin -101.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 146%
3 years · compounded
▲ 559%
EBITDA CAGR growth
1 year
▼ 390%
3 years · compounded
▼ 344%

Revenue has grown at a compounded annual rate (CAGR) of 559% over three years, including 146% growth in the latest year. EBITDA fell 390% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.95 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.14 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-101.7%
Net Profit Margin-167.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Refex Life Sciences Private Limited, buy the company report.

Board of directors of Refex Life Sciences Private Limited

Refex Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dinesh Kumar AgarwalDirector03 Mar 20215 Years 8 MonthsCurrent
Anil JainAdditional Director11 Nov 20251 Years 0 MonthsCurrent

Auditor

Refex Life Sciences Private Limited is audited by ABCD & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ABCD & CoFY 2023016415S

Shareholding

The shareholding of Refex Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Refex Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹460 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹460.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jul 2025101161332Others₹335 CrOpen
17 May 2023100720123Others₹125 CrOpen

To see the full charge records of Refex Life Sciences Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Refex Life Sciences Private Limited has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.

Total deals
2
Convertible or debt financing
1
Secondary share transfer
1
Disclosed funding
₹130 Cr

Deals on record (1 of 2)

WhenDealAmountParties
Jun 2021Secondary share transferUndisclosedBuyer: Sherisha Technologies Private Limited
Seller: an individual

To see the full deal history of Refex Life Sciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Refex Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Refex Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAUCA8721D1ZNTamil NaduActive15 Mar 2023

To see the full GST registrations and return filing status of Refex Life Sciences Private Limited, buy the company report.

Recent activity

Refex Life Sciences Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Anil Jain was appointed as Additional Director on 11 Nov 2025.

Charges
A charge with Others of Rs. 335.00 Cr registered on 30 Jul 2025 with Charge ID 101161332 was modified on 24 Dec 2025.
Appointed
Anil Jain was appointed as Additional Director.
Ceased
Patrik Vijay Kumar Francis Arun Kumar ceased to be Director.
AGM
Refex Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 335.00 Cr with Charge ID 101161332 was registered on 30 Jul 2025.
Ceased
Puthuseri Veedu Pasupathy ceased to be Whole-Time Director.
Filing
Refex Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Puthuseri Veedu Pasupathy was appointed as Whole-Time Director.
Charges
A charge with Others of Rs. 125.00 Cr registered on 17 May 2023 with Charge ID 100720123 was modified on 09 Jun 2023.
Charges
A charge with Others amounted to Rs. 125.00 Cr with Charge ID 100720123 was registered on 17 May 2023.
Ceased
Chandresh Jain ceased to be Director.
Appointed
Patrik Vijay Kumar Francis Arun Kumar was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Refex Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 03 March 2021 (5+ years old) and is registered under CIN U33112TN2021PTC141761.

Refex Life Sciences has 2 current directors:

The latest financial statements of Refex Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Refex Life Sciences is 33AAUCA8721D1ZN, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Refex Life Sciences is U33112TN2021PTC141761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Refex Life Sciences has 2 court cases on record: 2 filed against it.

Refex Life Sciences was incorporated on 03 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.

Refex Life Sciences has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.

Anil Jain was appointed as Additional Director on 11 Nov 2025. Patrik Vijay Kumar Francis Arun Kumar ceased to be Director on 11 Nov 2025. Puthuseri Veedu Pasupathy ceased to be Whole-Time Director on 01 Apr 2025. Refex Life Sciences has 8 board changes on record in total.

Refex Life Sciences can be reached through the website refex.co.in. Its registered office is in Chennai, Tamil Nadu, India.